Skip to content

Efficacy test of the topical agent CIB01

Efficacy test of the topical agent CIB01 - Efficacy test of the topical agent CIB01

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000029581
Enrollment
25
Registered
2017-10-20
Start date
2017-10-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Apply the formulation including an active ingredient to the one side of thigh and the placebo to other side of thigh twice a day for 12 weeks

Sponsors

Kao Corporation
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Healthy females

Exclusion criteria

Exclusion criteria: -Subjects who went to a hospital or been received medication for treatment of diseases within the last 1 month. -Subjects with a history or have been suffered from cardiovascular disease (Such as irregular pulse, angina pectoris, cardiac insufficiency). -Subjects who are pregnant, planning a pregnancy and lactating. -Subjects who are more sensitive to soaps, alcohol, velcro, adhesive tape, water-based gel, or permanent marker ink. -Subjects who underwent liposuction. -Subjects who had weight change of more than 5 kg within the last 3 months. -Subjects with atopic dermatitis, contact dermatitis, cutaneous hypersensitivity, any type of skin condition (such as eczema, skin irritation, or skin infection) -Subjects who participated in another clinical study applying agent or performing tape stripping to test site during this study or within 1 month before this study. -Subjects who participated in another clinical study eating foods during this study or within 1 month before this study. -Subjects who recieved special body care treatment for legs such as application of slimming cosmetics, massage by cosmetic instruments and esthetic treatment during this study or within 1 month before this study. -Subjects who have been suffered from a critical disease. -Subjects deemed inappropriate to participate in this study by the principle investigator.

Design outcomes

Primary

MeasureTime frame
Thigh circumference and subcutaneous fat layer thickness at 0, 6 and 12 weeks after the topical application.

Countries

Japan

Contacts

Public ContactErina Maeyama

Kao Corporation Biological Science Research

maeyama.erina@kao.co.jp+81-285-68-7579

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026